Cargando…
To escalate thromboprophylacic heparin intensity in COVID‐19 or not? That is still the question
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148841/ https://www.ncbi.nlm.nih.gov/pubmed/35664534 http://dx.doi.org/10.1002/rth2.12738 |